• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

平衡血管扩张剂氟司喹南对衰竭心脏主动脉阻抗的影响。

Effects of balanced vasodilator, flosequinan, on aortic impedance in failing heart.

作者信息

Yano M, Kohno M, Yamamoto T, Hisaoka T, Tanigawa T, Ono K, Lee B, Konishi M, Matsuzaki M

机构信息

Second Department of Internal Medicine, Yamaguchi University School of Medicine, Ube, Japan.

出版信息

J Cardiovasc Pharmacol. 1998 Sep;32(3):466-70. doi: 10.1097/00005344-199809000-00018.

DOI:10.1097/00005344-199809000-00018
PMID:9733361
Abstract

An arteriovenous vasodilator, flosequinan, has been shown to be effective for the treatment of acute heart failure. However, little is known as to its effect on aortic impedance, which is known to be a proper and precise expression of left ventricular (LV) afterload. To evaluate the acute cardiovascular effect of flosequinan in failing heart, we administered flosequinan intravenously to seven dogs with cardiac failure produced by an infusion of carbon powder (20-50 microm in diameter) into left main trunks of coronary artery. The LV-pump function was severely impaired after intracoronary injection of carbon powder, as evidenced by the findings that cardiac output, circumferential shortening velocity (mean Vcf), and peak +dP/dt of LV pressure were all decreased, associated with a significant increase in LV end-diastolic pressure. Flosequinan (0.9 mg/kg, i.v.) increased cardiac output by 28%, mean Vcf by 44%, and peak +dP/dt by 24%, whereas it decreased total systemic resistance by 32%, time constant of LV pressure decay by 22%, and LV end-diastolic pressure by 18%. Moreover, flosequinan substantially decreased the pulsatile components of LV afterload (i.e., characteristic impedance by 11% and arterial wave reflection coefficient by 45%). Thus flosequinan exerted not only positive inotropic but also positive lusitropic effects, in association with a significant reduction of both pulsatile and steady components of LV afterload, contributing to an improvement of LV-pump function in acute cardiac failure.

摘要

一种动静脉血管扩张剂氟司喹南已被证明对治疗急性心力衰竭有效。然而,关于其对主动脉阻抗的影响却知之甚少,而主动脉阻抗是左心室(LV)后负荷的一种恰当且精确的表达。为了评估氟司喹南对衰竭心脏的急性心血管作用,我们对7只通过向冠状动脉左主干内注入碳粉(直径20 - 50微米)而导致心力衰竭的犬静脉注射氟司喹南。冠状动脉内注射碳粉后左心室泵功能严重受损,心输出量、圆周缩短速度(平均Vcf)和左心室压力峰值 +dP/dt均降低,同时左心室舒张末期压力显著升高,这些结果证明了这一点。氟司喹南(0.9毫克/千克,静脉注射)使心输出量增加28%,平均Vcf增加44%,峰值 +dP/dt增加24%,而全身总阻力降低32%,左心室压力衰减时间常数降低22%,左心室舒张末期压力降低18%。此外,氟司喹南显著降低了左心室后负荷的脉动成分(即特征阻抗降低11%,动脉波反射系数降低45%)。因此,氟司喹南不仅发挥了正性肌力作用,还发挥了正性松弛作用,同时显著降低了左心室后负荷的脉动和稳定成分,有助于改善急性心力衰竭时的左心室泵功能。

相似文献

1
Effects of balanced vasodilator, flosequinan, on aortic impedance in failing heart.平衡血管扩张剂氟司喹南对衰竭心脏主动脉阻抗的影响。
J Cardiovasc Pharmacol. 1998 Sep;32(3):466-70. doi: 10.1097/00005344-199809000-00018.
2
Positive inotropy contributes to the hemodynamic mechanism of action of flosequinan (BTS 49465) in the intact dog.正性肌力作用有助于氟司喹南(BTS 49465)在完整犬体内的血流动力学作用机制。
J Cardiovasc Pharmacol. 1990 Jun;15(6):900-10. doi: 10.1097/00005344-199006000-00007.
3
Effect of flosequinan (BTS 49465) on myocardial oxygen consumption.氟司喹南(BTS 49465)对心肌耗氧量的影响。
Am Heart J. 1990 Jun;119(6):1355-66. doi: 10.1016/s0002-8703(05)80186-3.
4
Effects of low-dose flosequinan on left ventricular systolic and diastolic chamber performance.低剂量氟司喹南对左心室收缩和舒张功能的影响。
Am Heart J. 1994 Jul;128(1):124-33. doi: 10.1016/0002-8703(94)90018-3.
5
Positive inotropic and hemodynamic properties of flosequinan, a new vasodilator, and a sulfone metabolite.新型血管扩张剂氟司喹南及其砜代谢产物的正性肌力和血流动力学特性。
J Cardiovasc Pharmacol. 1989 Sep;14(3):412-8. doi: 10.1097/00005344-198909000-00009.
6
Positive inotropic and lusitropic effects of intravenous flosequinan in patients with heart failure.静脉注射氟司喹南对心力衰竭患者的正性肌力和变时性作用。
J Am Coll Cardiol. 1992 Oct;20(4):822-9. doi: 10.1016/0735-1097(92)90179-q.
7
Flosequinan: a vasodilator with positive inotropic activity.氟司喹南:一种具有正性肌力活性的血管扩张剂。
Am Heart J. 1991 Feb;121(2 Pt 1):537-40. doi: 10.1016/0002-8703(91)90723-u.
8
Flosequinan, a new vasodilator: systemic and coronary hemodynamics and neuroendocrine effects in congestive heart failure.氟司喹南,一种新型血管扩张剂:充血性心力衰竭中的全身及冠状动脉血流动力学和神经内分泌效应
J Am Coll Cardiol. 1992 Dec;20(7):1542-8. doi: 10.1016/0735-1097(92)90448-v.
9
Disparate inotropic and lusitropic responses to pimobendan in conscious dogs with tachycardia-induced heart failure.在患有心动过速诱发心力衰竭的清醒犬中,匹莫苯丹引发的变力性和变时性反应存在差异。
J Cardiovasc Pharmacol. 1994 Feb;23(2):268-74.
10
Sustained hemodynamic response to flosequinan in patients with heart failure receiving angiotensin-converting enzyme inhibitors.接受血管紧张素转换酶抑制剂治疗的心力衰竭患者对氟司喹南的持续血流动力学反应。
J Am Coll Cardiol. 1993 Oct;22(4):963-7. doi: 10.1016/0735-1097(93)90404-o.